Tech Company Financing Transactions
GenomeDx Biosciences Funding Round
GenomeDx Biosciences, based in Vancouver BC, scored $25.4 million from private investors.
Transaction Overview
Company Name
Announced On
3/10/2016
Transaction Type
Venture Equity
Amount
$25,385,034
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 27 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1152 Mainland St. 430
Vancouver BC, V6B 4X2
Canada
Vancouver BC, V6B 4X2
Canada
Phone
Website
Email Address
Overview
GenomeDx is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Medical Officer
Douglas Dolginow
President
Elai Davicioni
VP - General Counsel
Adam Chinnock
Browse more venture capital transactions:
Prev: 3/10/2016: PolyPlexx venture capital transaction
Next: 3/10/2016: Icertis venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site come from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs